Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Allogene Therapeutics, Inc. (ALLO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
Docs: "Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update"
07/10/2023 SC 13G FMR LLC reports a 17.1% stake in ALLOGENE THERAPEUTICS INC
06/29/2023 144 Form 144 - Report of proposed sale of securities:
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/07/2023 8-K Other Events  Interactive Data
04/24/2023 ARS Form ARS - Annual Report to Security Holders:
04/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/24/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/20/2023 8-K Quarterly results
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/28/2023 10-K Annual Report for the period ended December 31, 2022
02/28/2023 8-K Quarterly results
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G VANGUARD GROUP INC reports a 5% stake in Allogene Therapeutics Inc.
02/03/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2023 SC 13G BlackRock Inc. reports a 6.2% stake in Allogene Therapeutics, Inc
01/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/29/2022 8-K Quarterly results
11/02/2022 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
11/02/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/02/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
09/21/2022 8-K Other Events  Interactive Data
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/09/2022 8-K Quarterly results
Docs: "Allogene Therapeutics Reports Second Quarter 2022 Financial Results"
07/20/2022 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
07/12/2022 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
07/12/2022 8-K Quarterly results
06/21/2022 SC TO-I Form SC TO-I - Tender offer statement by Issuer:
06/17/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy